CLOs on the Move

Vicor Technology

www.vicortech.com

 
Frp, Web: Vicor Technologies, Inc (OTCBB: VCRT) is a bio-technology company focused on the development and commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients: •at risk of sudden cardiac death or autonomic nervous system dysfunction, and •trauma victims in need of immediate lifesaving intervention.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.vicortech.com
  • 2300 NW Corporate Blvd Ste 123
    Boca Raton, FL USA 33431
  • Phone: 800.998.9964

Executives

Name Title Contact Details

Similar Companies

Chrono Therapeutics

We provide more. We are building a next generation transdermal drug delivery wearable that integrates biologically-timed drug delivery with personalized digital support to help people achieve optimal clinical outcomes and lifestyle improvements.

Blue Medical Supply and Equipment

Blue Medical Supply and Equipment is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Zeus Scientific Inc

Zeus Scientific Inc is a Branchburg, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Progressive Medical International

Progressive Medical International is a Vista, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Smith and Nephew

Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange   We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.   We have almost 11,000 employees and a presence in more than 90 countries.   Annual sales in 2013 were more than $4.3 billion.   We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)